Lifetime risk, estimated frequency, types (such as ovarian, prostate, pancreatic and others) and characteristics (such as estrogen‐receptor expression) of cancers also vary between individuals with BRCA1 and BRCA2 mutations (Roy et al., 2012). Here, BRCA2 is linked to cancer.